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Abstract This paper focuses on the design and development of a noninvasive smart and pervasive mobile solution to measure blood glucose
without the need for drawing blood or pricking fingers. Specifically, it
examines the possibility of sensors using Terahertz (THz) technology to
measure blood glucose. This paper reports on a research in progress looking
at identifying and then designing superior strategies for measuring blood
glucose. It presents the central role that measuring blood glucose plays in
diabetes care management. It then highlights the current methods and
problems and concerns with finger pricking. From there, the paper proffers
a non-invasive solution using THz technology to measure blood glucose
and outlines the approach to design and develop such a solution using a
decision science methodology.
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Introduction
Diabetes is a chronic disease that occurs when there is too much glucose in the blood
because the body is not producing insulin or not using insulin properly (Diabetes
Australia, 2007). As noted by the WHO (World Health Organization, 2016), diabetes is
at epidemic proportions globally and needs to be addressed. Diabetes management
involves a combination of both medical and non-medical approaches with the overall goal
for the patient to enjoy a life which is as normal as possible (Australian Institute of Health
and Welfare, 2007, 2008). As there is no cure for diabetes, diabetes must be regularly
managed and monitored. Critical to this management regimen is the systematic
monitoring of blood glucose levels. However, achieving this goal can be challenging
because it requires effective lifestyle management as well as careful, meticulous attention
and monitoring by the patient and health professionals (Britt et al., 2007). There is a need
for identifying a simple and convenient non-invasive approach to monitoring blood
glucose (So et al., 2012). This forms the focus of this research.
Background
2.1

Invasive, Semi-Invasive, and Non-Invasive Solutions

A key factor in the management of diabetes has been found to be the patient’s self blood
glucose monitoring (SBGM) (Guerci et al., 2003; Haller et al., 2004; Karter et al., 2001).
As a result of recent research (Farmer et al., 2009; Malanda et al., 2012), General Practice
Management of type 2 diabetes (RACGP and Diabetes Australia, 2014-2015)
recommends SMBG for patients with type 2 diabetes who are on insulin. Currently, the
dominant method to test blood glucose level is invasive. It requires a blood glucose meter,
a lancet device with lancets, and test strips. Further, the patient must prick their finger
with the lancet sometimes more than four times a day. Finger pricking in SBGM has been
found to have several clinical and psychological disadvantages. These are described
below.
Clinically, there is a risk of skin infection and tissue damage. Repeated finger pricking
associated with the depth and possible vibrations of the needle tip while penetrating the
skin were found to cause soreness (Burge, 2001) and damage the skin and in severe cases
could lead to ulcer on their patient fingers (Dahiya et al., 2012; Giannini & Mayr, 2004).
Therefore, this SBGM practice can result in damage to the patient body site.
Further, SBGM using a finger prick glucometer is not practical for continuous monitoring
of blood glucose (So et al., 2012). As blood glucose levels of a patient change overtime,
possible occurrences of hyperglycaemia or hypoglycaemia between measurements may
not be recorded. Thus, the measurements may not truly reflect the patient blood glucose
pattern (Kannampilly, 2013).
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Psychologically, inconvenience and anxiety of constant performing finger pricking and
extracting a drop of blood in patients’ daily lives, and associated physical and emotional
pain have always been troublesome in SBGM (Burge, 2001; Karges et al., 2008; Pacaud
et al., 1999; Wainstein et al., 2013). In a cross-sectional questionnaire survey with 315
patients with diabetes in the UK, about one third of general diabetes patients were found
to have anxiety to finger pricking for SBGM (Shlomowitz & Feher, 2014). Positive
correlations were found between anxiety due to finger pricking and avoidance of testing
as well as between anxiety due to finger pricking and general anxiety. In previous studies
(Burge, 2001; Cradock & Hawthorn, 2002; Koschinsky, 2007), pain and discomfort were
consistently found to cause a natural resistance to SBGM, and subsequently result in a
lack of adherence to this procedure. Anxiety due to the finger prick method and avoidance
of testing were found across different ethnic groups and female patients were found to
have greater anxiety to finger pricking SBGM (Shlomowitz & Feher, 2014).
The aforementioned disadvantages served to motivate the need for new approaches to
SBGM. They can be categorised into two groups. The first group is to support for
measuring blood glucose levels in a less painful manner. Wainstein et al. (2013) used a
CoolSense device to reduce local pain sensation due to finger pricking. They conducted
an experiment with 177 adult patients with type 2 diabetes and concluded that the
CoolSense device significantly reduced subjective pain felt by the patients while
maintaining the same level of clinical accuracy. Other studies suggest that instead of
pricking fingers, patients can prick other areas such as the forearm, knee, earlobe, thigh
and abdomen skin (Castilla-Peón et al., 2015; Heinemann, 2008; Nakayama et al., 2008).
While pricking alternative body sites were commonly found to reduce pricking fingers to
some extent, it did not eliminate the pain completely. Disadvantages of pricking other
body sites include lack of accuracy, inconvenience and difficulty of pricking in public,
and technology switching costs to purchase new equipment for pricking and measurement
(Castilla-Peón et al., 2015; Cradock & Hawthorn, 2002; Heinemann, 2008).
The second group of approaches to SBGM is to developing semi-invasive and noninvasive technologies for blood measuring without needle pricks (Makaram et al., 2014;
So et al., 2012). Du et al. (2016) propose a biosensor that can detect low-level glucose in
saliva. They conducted a study of ten healthy human subjects and conducted that the
proposed biosensor can be seen as a potential alterative to SBGM using finger pricking.
The protocol of use is still rather complex, consisting of nine steps requiring the patient
to chew a sponge in his/her mouth to collect saliva, and later squeeze the collected saliva
into the device with a sensor, thus is not easy to use. More studies are required to
investigate the accuracy of sensors in detecting low salivary glucose levels, efficiency
and practicality of the proposed approach. Zhang et al. (2011) review current
developments of non-invasive continuous SBGM methods using ocular glucose. These
authors review studies in ocular glucose monitoring: (1) using contact lens-based sensors
and (2) using nanostructured lens-based sensors. They concluded that lens sensors have
the potential to monitor a wide range of glucose levels quickly and accurately, however
there is a safety concern because boronic acid and concanavalin A may be released from
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the lens into the patient body. Nanostructured lens-based sensors have several advantages
(for example better accuracy and sensitivity, less interference with patient vision), further
studies are required to improve resolution and sensitivity of the lens, and to determine
physiologically relevance and baseline tear glucose concentration (Zhang et al., 2011).
Another review of current nanomaterial-based solutions using saliva, sweat, breath and
tears as a medium for SBGM suggests that they are far from optimal; further
nanotechnology sensing devices need to be manufactured at a low cost to compete with
established blood glucose meters (Makaram et al., 2014).
One of the most recent advances in the area of semi-invasive glucose monitoring is
Abbott’s Freestyle Libre System (HT Correspondent, 2015) which is based on a body
attached sensor and a smartphone loaded with the application (Figure 1, adapted from HT
Correspondence, 2015). This disposable body attached device (sensor) is equipped with
a thin and flexible fibre needle, which is the only invasive part, however the fibre is
inserted only once and under the skin of the back of the arm. The sensor can be used
continually for 14 days without the need to be replaced. The sensor captures glucose
concentration information and once the smartphone that runs the required app scans the
sensor, the current and up to 8 hours of glucose levels are read and uploaded to the
smartphone (Timothy et al., 2015)

Figure 1: Freestyle Libre System, (adapted from Hindustan Times, HT
Correspondent (2015)
According to Timothy et al. (2015), the accuracy of the FreeStyle Libre system as
dependent function of a number of patient-related factors (e.g., diabetes type, gender,
insertion site/administration, body mass index, hemoglobin A1c “HbA1c”, age, and rate
of change) has been found to be above 85.2% up to 14 days of testing.
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Overall, studies in issues associated with SBGM using finger pricking devices and
learnings from in current developments of new SBGM methods suggest the following
key factors: technology (technical soundness, sensitivity of device, and sufficient
quantity and reproduction of medium), clinical accuracy (accuracy of measures,
continuity of monitoring), clinical and safety interference with vision patient vision
(infection, damage to patient body sites, release of chemicals to patient body, interference
with patient vision), ease of use (level of invasiveness, practicality of sample collection
and protocols of use), psychological effects (pain and discomfort, anxiety, fear,
inconvenience and difficulty of performing tests in public), and costs (manufacturing
costs and patient technology switching costs). We develop Table 1 to present the key
aspects of problems and concerns identified in the extant literature relating to SBGM.
We conceptualise the problem in diabetes care management with the above factors.
Therefore, we propose an approach to solution development consisting of patients
analytics to focus on the targeted patient cohort, design science engaging patients in
testing when it's safe, not early design, to finally propose a new solution to address their
concerns and ensuring appropriate monitoring of the care management plan.

12
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Table 1: Problems and concerns in current SBGM methods
Key aspects
Factors
Technical
Sufficient quantity and reproduction of medium (Makaram et al.,
feasibility
2014).
Sensitivity of device (Zhang et al., 2011)
Technical soundness (Makaram et al., 2014; So et al., 2012)
Clinical
Accuracy of result (Castilla-Peón et al., 2015; Nakayama et al.,
accuracy
2008; Timothy et al., 2015)
Continuity of monitoring (Kannampilly, 2013; So et al., 2012)
Side effects and Infection (Dahiya et al., 2012; Giannini & Mayr, 2004)
safety
Physical damage to the body site (Burge, 2001; Dahiya et al.,
2012; Giannini & Mayr, 2004)
Release of chemical to body (Zhang et al., 2011)
Interference with vision (Zhang et al., 2011)
Easy of use
Level of invasiveness (Castilla-Peón et al., 2015; Heinemann,
2008; So et al., 2012; Wainstein et al., 2013).
Practicality of device, sample collection and protocols of use (Du
et al., 2016; Heinemann, 2008)
Psychological
Pain and discomfort (Burge, 2001; Heinemann, 2008; Karges et
effects
al., 2008; Koschinsky, 2007; Pacaud et al., 1999; Wainstein et al.,
2013)
Anxiety and distress (Cradock & Hawthorn, 2002; Shlomowitz &
Feher, 2014)
Fear of needles and blood (Burge, 2001; Shlomowitz & Feher,
2014)
Inconvenience and difficulty of performing tests in public
(Castilla-Peón et al., 2015; Heinemann, 2008)
Costs

2.2

Manufacturing costs (Makaram et al., 2014)
Patient technology switching costs (Heinemann, 2008)
Non-Invasive Terahertz Technology Solution

The ultimate approach in managing diabetes is based on non-invasive solutions, one
approach is using Terahertz technology which is the focus of this section. Terahertz refers
to the electromagnetic waves with the frequency range between millimetre-wave and
infrared, approximately from 100 GHz up to 10 THz (see Figure 2 adapted from Adibi,
2013). The THz spectrum, also known as the “terahertz gap” is the last portion of the
electromagnetic spectrum which has not been fully explored and exploited (Tonouchi,
2007). Terahertz technology is a fast-growing field with applications in biology and
medicine, medical imaging, material spectroscopy and sensing, security, monitoring and
spectroscopy in pharmaceutical industry, and high-data-rate communications.
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In biomedicine, Terahertz technology has so far been used in variety of medical
applications, including: skin/breast cancer detection, wound inspection, and dental
imaging (Panwar et al., 2013; Yang et al., 2016).

Figure 2: Frequency Spectrum of EMR Imaging Technologies, adapted from Adibi
(2013)
The THz studies have uniquely revealed that medical image diagnoses are possible over
wide range of tissues, however much further detailed analyses are required to identify the
degree of precision achieved in monitoring blood glucose concentration using THz
technology.
Proposed solution
The technology methods behind the operation of this solution’s proof of concept are
based on the following approaches (Jackson et al., 2011):
-

Terahertz time-domain spectroscopy (THz-TDS)
Terahertz frequency-domain spectroscopy (THz-FDS)
Terahertz imaging using non-destructive evaluation (NDE)

These methods are considered to pinpoint the best option for blood-glucose level
monitoring from the transmitter/receiver perspectives. The THz transmitter, the
operational power, energy consumption level, and safety factors are of significant
importance since the solution is ultimately deployed in a smartphone application.
From the mentioned approaches, the THz-TDS approach has shown promising behaviour
since it was used to measure the full dielectric-based function representing as the
absorption coefficient and the refraction index of glucose and galactose between 0.2 THz
to 3.0 THz (Zhang, 2008). A few distinct absorption features are identified as the
signatures of intra- and intermolecular modes of the hydrogen bonded crystalline
structure.

14
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The design of the related app that runs on the smartphone platform requires a number of
features, including: a fast Digital Signal Processing (DSP) system based on the
microcontroller system used in the Arduino platform. The hardware side of the system
consists of an open-source 32-bit Atmel ARM processor, which is capable of running fast
concurrent processes. The software system features a fast and optimised image
processing algorithm aided with Kalman filtering for higher accuracy. The high accuracy
results are needed due to highly variable testing environment (handheld application). The
system also features remote monitoring and cloud-computing capability. The proof-ofconcept involves the identification of the optimal THz sensor, power, frequency
spectrum, and reflection analysis for the most optimal application of the Terahertz
technology in monitoring under-skin blood glucose levels.
The framework is the continuation of the work of reference (Shen et al., 2002), which is
based on the Fourier Transform Infrared (FTIR) Spectroscopy. This reference shows the
successful deployment of infrared in detecting glucose level of the blood. The lessons
learned from this work can directly be used in this project.
Once the specific THz approach is selected, the methodological approach is to model the
existing solutions and study the physical behaviour of Terahertz technology when
radiated onto the human skin and study the depth of penetration and the variations in the
reflections. This requires sophisticated THz lab equipment to run experiments on a test
dummy, which mimics the human skin and underlying soft tissues. The results between
the traditional needle-based sensing are then compared and the precision figures for the
Terahertz-based method are evaluated. Then the approach need to be fine-tuned and also
other health issues (e.g., technology implications, training, health-hazards, etc.) are then
considered.
Proposed solution
A Design Science Research Methodology (DSRM) will be used to operationalize this
research. This approach is particularly appropriate where improving an existing solution
is desired and/or there is a need for a new solution to address specific unsolved or unique
aspects (Hevner & Chatterjee, 2010; Hevner et al., 2004). DSRM as a process model to
carry out research is widely used in the information systems research to create new
solutions or to improve existing ones. DSRM process model consists of six process
elements (Peffers et al., 2007), starting from identifying the problem and the motivation
to conduct research, and concluding with communicating the results and outcomes of the
research. Table 2 maps the proposed project to DSRM process elements (Peffers et al.,
2007).
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DSRM process
elements
Problem
identification
and motivation

Definition of
objectives of
the solution

Design and
development

Demonstration
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Table 2: Mapping the proposed research to DSRM
DSRM description
Application on this study
Defining the specific
research problem and
justifying the value of a
solution based on
knowledge of the state of
the problem.
The objectives can be
qualitative or quantitative
i.e. create or improve an
artefact respectively based
on knowledge of the state
of the problem and
current solutions, if any,
and their efficacy.
Creating the artefact,
including the desired
functionality and its
architecture based of
knowledge of theory that
can be used to bear in a
solution. This is usually
an iterative process.
Demonstrate the use of
the artefact to solve the
problem.

Evaluation

Iterate back to better
design the artefact if
needed.

Communication

Publish and let the value
of the solution talk about
itself.

With the increased diabetes
population, and the disadvantages of
conventional blood glucose tests, the
lack of a reliable and easy to use noninvasive technology to monitor blood
glucose motivates this research.
The objective is to create and refine
an artefact; i.e. the sensors.

Through several iterations the exact
range for the frequency for the needed
Terahertz wave beam will be
identified. Once the narrow range for
the frequency for the Terahertz wave
is identified, the CAD/CAM
programming will occur.
Simulation-based: This will be done
in a lab using their simulation set up
and mannequins.
Clinical: Demonstration of the use of
a new device to a sample of targeted
patient population.
Simulation-based: As needed,
iterations will take place, to fine tune
the needed range for the Terahertz
wave projections.
Clinical: Iterative evaluations to
ensure that the prototype is truly
tailored to meet clinical requirements
for the targeted population.
This will include conference
publications, journal publications and
other presentation activities.
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Results and Next Steps
Based on our systematic review of the literature to date, we have identified problems and
concerns with the current methods for blood glucose monitoring as well as the need for a
simple, accurate non-invasive solution to it. To address this void we have proffered a
technology solution using sensor technology combined with a smart phone. The next
steps now include the design and development of the solutions coupled with
establishment of proof of concept, usability and fidelity. This involves four key steps as
follows:
Phase1: This phase will involve the conducting of multi-dimensional analysis of provided
data sets from a diabetic population (in China). The results will provide a clear picture of
the current state, reveal critical trends and important patterns regarding this population
and assist to identify the patient sample. It is anticipated that target patient cohorts and
their demographics as well as geographic and clinical characteristics will be identified
for the project to identify who would benefit most from the non-invasive smart solutions.
This phase aims to address the first DSRM process elements including problem
identification and motivation, and definition of objectives of the solution (see Table 2).
Phase 2: Phase 2 will include designing and developing the appropriate sensor
technology. The patented solution we have developed uses THz to identify blood sugar
readings but this requires critical analysis to isolate the specific THz band. Inputs for this
are derived from aspects of the data analytics performed in phase 1 above. Once this is
done the required specifications for designing the sensors must be generated. Thus the
results at the end of this phase include the design specification for the sensors to be used
in the specific context so they are truly tailored to that context. This phase aims to address
the subsequent DSRM process elements including design and development, simulationbased demonstration, and associated simulation-based evaluation.
Phase 3: Phase 3 will focus on the design and development of the software solution
necessary to develop the prototype to be used to measure blood glucose readings.
Contemporaneously, the health literacy issues will be examined and an appropriate
education and coaching program will be developed for the targeted population. This
phase aims to continue the DSRM process element design and development.
Phase 4: Phase 4 involves establishment of proof of concept, usability, fidelity and
functionality. This will be conducted by running a field study on the selected patient
population of 50 patients based on results from phase 1. It is anticipated that the filed
study will involve and iterative process to ensure that the prototype is truly tailored to the
selected population’s needs and requirements. In addition, HbA1C the standard diabetes
marker will be tested at 3 month intervals over a 6 month time frame to assess success of
the solution and changes to health literacy at these points will also be assessed. This phase
aims to address the DSRM process elements including clinical demonstration, and
clinical evaluation using the key aspects (technical feasibility, clinical accuracy, clinical
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side effects and safety, ease of use, psychological effects, and costs) and relevant factors
presented in Table 1. As a result, the list of factors will be refined to inform future
implementations and evaluations.
The DSRM process element communication will take place through the whole project
when findings from each phase become available.
Discussion and Conclusion
Concurrent and independent from the exponential rise of diabetes has been the rise of
mobile and sensor technology. The maturing and sophistication of these technologies has
enabled them to be sued in many aspects of healthcare and wellness management. The
preceding has served to outline another potential area for the adoption of mobile and
sensors; namely, to assist with a non-invasive approach for the monitoring and
management of diabetes. Specifically, we have identified an opportunity to use Terahertz
frequencies to detect blood glucose levels in individuals. Further, we envisage designing
and developing this solution by combining sensors with a mobile phone so that detection
of blood glucose can not only be non-invasive but truly pervasive.
The implications for theory and practice are wide and far reaching. From a theoretical
perspective we combine two technology genres mobile and sensors to address a
healthcare issue – detection of blood glucose levels using a design science research
methodology. This can lead to a better understanding and application of sensor
technology in mobile technology. Scientifically backed roadmaps for including
innovative sensors (i.e. terahertz sensors) in mobile technology can support further
DSRM based research in the field. From the perspective of practice, diabetes as noted by
World Health Organization (2016) is global and at epidemic proportions with an
estimated of 422 million adults living with diabetes in 2014, and 1.5 million deaths caused
by diabetes in 2012. Complications from diabetes can lead to other serious conditions
such as heart attack, stroke, blindness, kidney failure and lower limb amputation. Further,
the number of pre-diabetic individuals is also considerable. Monitoring and management
is the only recognised strategy to maintaining appropriate blood glucose levels and
thereby managing diabetes and/or preventing a pre-diabetic becoming a diabetic. Given,
the problems and criticisms of finger pricking and other invasive approaches to SBGM,
the most prevalent approach to testing blood glucose using a non-invasive Terahertz
technology solution which we propose is very attractive to individuals. By learning from
glucose monitoring, there is an opportunity to transfer the use of Terahertz technology to
test other blood values in a non-invasive way. When such a solution is truly pervasive, it
becomes even more attractive. Thus, we believe that the proffered solution will enable
diabetic and pre-diabetic individuals to enjoy a better quality approach to monitoring and
managing their blood glucose levels.
Our future work will focus on establishing usability, fidelity and acceptability of the
proffered non-invasive pervasive solution
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